Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
PSBD Palmer posts steep earnings miss reports 119 EPS vs 051 forecast shares decline 109 HOLOW MicroCloud investors seek details on hologram business growth drivers as latest quarterly earnings omit core financial metrics TPTA Terra outlines targeted rental income growth priorities in its latest quarterly earnings report Keysight Technologies KEYS Stock Is It Testing Key Levels Bullish Sentiment 20260420 United Parcel Service UPS What affects John HTD stock price Vertex Pharmaceuticals VRTX Robust Casgevy Early Launch Metrics Spark Counterintuitive Selloff for CoCommercialization Partner CRISPR Therapeutics HOOD Robinhood Markets drops 1324 after Q1 2026 EPS lands 125 short of consensus analyst estimates UVE UNIVERSAL delivers 425 percent Q1 2026 EPS beat shares rise 314 percent on upbeat investor reaction TCW Turns to Emerging Market Oil Exporter Debt Amid WarDriven Energy Shifts STERIS plc STE Flat at 21287 Consolidation Continues 20260518 Cybin HELP Q1 2026 Results Fall Short EPS 139 Revenue NA Fervos Geothermal Vision A 10 Billion Player in Americas AI Infrastructure Boom Icon ICON Reports Weak Q4 2025 Cost Pressures Weigh on Margins Nvidia Revenue Surpasses Wall Street Expectations as AI Infrastructure Expansion Accelerates Autonomix AMIX Q1 2026 Earnings 036 EPS Surges Past 060 Estimates European Stocks Climb as Markets Weigh UK Inflation Data and Elevated Bond Yields Danaher Q1 2026 Earnings Earnings Per Share Beats Estimates Amid Slight Stock Pullback NovaBridge Biosciences NBP Q4 2025 Earnings Staggering EPS Miss as PreRevenue Biotech Faces Development Headwinds GEOS Q1 2026 Earnings Losses Reported Stock Edges Lower QUIK Q1 2026 Earnings EPS Misses Estimates as Stock Rises 13 ACGLN Q1 2026 Earnings Preferred Share EPS Falls Slightly Short of Estimates Stock Edges Higher Allogene Therapeutics ALLO Surges 6 Can the Biotech Reclaim Key Resistance Advanced Flower Capital AFCG Edges Higher Amid Tight Trading Range Key Levels in Focus Aether Holdings ATHR Faces Selling Pressure Testing Key Support After 3 Decline Greenlight Capital Re Ltd GLRE Slips 251 as Price Pivots Near Key Resistance Zone